Skip to main content
. 2021 May 21;11(6):930. doi: 10.3390/diagnostics11060930

Table 1.

Clinical characteristics and tumor markers in patients with tuberculoma vs. those with adenocarcinoma.

Characteristics Tuberculoma
no. (%)
Adenocarcinoma
no. (%)
Total
no. (%)
p-Value
No. 31 30 61
Sex 0.527 1
Female 13 (41.9%) 15 (50.0%) 28 (45.9%)
Male 18 (58.1%) 15 (50.0%) 33 (54.1%)
Age <0.001 2
Mean (SD) 46.8 (12.3) 61.1 (9.9) 53.8 (13.2)
Median [Q1, Q3] 50.0 [35.0, 57.5] 61.5 [53.5, 70.0] 56.0 [44.0, 63.0]
Range 28.0–64.0 41.0–77.0 28.0–77.0
Smoker 11 (35.5%) 12 (40.0%) 23 (37.7%) 0.716 1
Smoking index 0.545 2
Mean (SD) 166.13 (285.59) 349.67 (789.56) 256.39 (592.16)
Median [Q1, Q3] 0.00 [0.00, 175.00] 0.00 [0.00, 425.00] 0.00 [0.00, 200.00]
Range 0.00–900.00 0.00–4000.00 0.00–4000.00
Underlying disease
Emphysema 6 (19.4%) 10 (33.3%) 16 (26.2%) 0.215 1
Diabetes 5 (16.1%) 5 (16.7%) 10 (16.4%) 0.955 1
Tumor marker
CA125, >35 U/mL 0.063 2
N-Miss 21 13 34
Median [Q1, Q3] 7.80 [4.73, 11.70] 12.10 [10.10, 17.20] 10.70 [7.80, 16.20]
CEA, >5 ng/mL 0.057 2
N-Miss 16 8 24
Median [Q1, Q3] 1.63 [1.25, 2.26] 2.21 [1.72, 4.72] 1.97 [1.57, 3.65]

1 Pearson’s chi-square test; 2 Mann–Whitney rank sum test. Abbreviations: no., number; SD, standard deviation; N-Miss, number of missed; CEA, carcinoembryonic antigen.